| 1 | Hypoxia-ischemia and retinal ganglion cell damage (10.2147/opth.s3361) | Abstract References ORCID License | 237.84 | 238 |
| 2 | The challenge of dry eye diagnosis (10.2147/opth.s1496) | Abstract References ORCID License | 230.10 | 199 |
| 3 | Age and disease-related structural changes in the retinal pi… (10.2147/opth.s2151) | Abstract References ORCID License | 227.42 | 187 |
| 4 | Cystoid macular edema (10.2147/opth.s4033) | Abstract References ORCID License | 217.61 | 149 |
| 5 | Etiology, prevalence, and treatment of dry eye disease (10.2147/opth.s5555) | Abstract References ORCID | 197.28 | 426 |
| 6 | Uveal melanoma: epidemiology, etiology, and treatment of pri… (10.2147/opth.s89591) | Abstract References ORCID | 190.24 | 343 |
| 7 | Use of viscoelastic substance in ophthalmic surgery&nbsp… (10.2147/opth.s1439) | Abstract References ORCID License | 189.21 | 77 |
| 8 | Treatment of chronic dry eye: focus on cyclosporine (10.2147/opth.s1409) | Abstract References ORCID License | 186.92 | 73 |
| 9 | Review of moxifloxacin hydrochloride ophthalmic solution in… (10.2147/opth.s1666) | Abstract References ORCID License | 182.61 | 66 |
| 10 | Meta-analysis and review: effectiveness, safety, and central… (10.2147/opth.s111620) | Abstract References ORCID | 178.79 | 241 |
| 11 | Associations between signs and symptoms of dry eye disease:… (10.2147/opth.s89700) | Abstract References ORCID | 176.70 | 226 |
| 12 | Management of ocular inflammation and pain following catarac… (10.2147/opth.s4806) | Abstract References ORCID License | 176.34 | 57 |
| 13 | Systemic side effects of eye drops: a pharmacokinetic perspe… (10.2147/opth.s118409) | Abstract References ORCID | 175.98 | 221 |
| 14 | The prevalence rates of refractive errors among children, ad… (10.2147/opth.s2836) | Abstract References ORCID License | 173.24 | 53 |
| 15 | Topical treatment options for conjunctival neoplasms (10.2147/opth.s1606) | Abstract References ORCID License | 172.43 | 52 |
| 16 | Micropulse diode laser trabeculoplasty (MDLT): A phase II cl… (10.2147/opth.s2303) | Abstract References ORCID License | 172.43 | 52 |
| 17 | Topical ophthalmic NSAIDs: a discussion with focus on nepafe… (10.2147/opth.s1067) | Abstract References ORCID License | 170.76 | 50 |
| 18 | Management of orbital fractures: challenges and solutions (10.2147/opth.s80463) | Abstract References ORCID | 169.33 | 180 |
| 19 | Micro-invasive glaucoma surgery (MIGS): a review of surgical… (10.2147/opth.s135316) | Abstract References ORCID | 166.51 | 165 |
| 20 | Risk factors for progression to blindness in high tension pr… (10.2147/opth.s3139) | Abstract References ORCID License | 166.28 | 45 |
| 21 | Treatment of cystoid macular edema with the new-generation N… (10.2147/opth.s4684) | Abstract References ORCID License | 166.28 | 45 |
| 22 | Pars plana vitrectomy for primary rhegmatogenous retinal det… (10.2147/opth.s1511) | Abstract References ORCID License | 164.35 | 43 |
| 23 | Brinzolamide ophthalmic suspension: a review of its pharmaco… (10.2147/opth.s3182) | Abstract References ORCID License | 164.35 | 43 |
| 24 | Long term results of a prospective randomized bilateral eye… (10.2147/opth.s27170) | Abstract References ORCID | 163.21 | 149 |
| 25 | Endophthalmitis: Pathogenesis, clinical presentation, manage… (10.2147/opth.s6461) | Abstract References ORCID | 163.21 | 149 |
| 26 | Association of treatment adherence with real-life VA outcome… (10.2147/opth.s151611) | Abstract References ORCID | 162.55 | 146 |
| 27 | Glial and endothelial blood-retinal barrier responses to amy… (10.2147/opth.s3967) | Abstract References ORCID License | 162.32 | 41 |
| 28 | Managing adverse effects of glaucoma medications (10.2147/opth.s44708) | Abstract References ORCID | 161.42 | 141 |
| 29 | The rate of symptomatic improvement of congenital nasolacrim… (10.2147/opth.s2582) | Abstract References ORCID License | 161.28 | 40 |
| 30 | Revisiting keratoconus diagnosis and progression classificat… (10.2147/opth.s44741) | Abstract References ORCID | 160.96 | 139 |
| 31 | Chronic central serous chorioretinopathy: long-term follow-u… (10.2147/opth.s115685) | Abstract References ORCID | 160.73 | 138 |
| 32 | Retinal vein occlusion: pathophysiology and treatment option… (10.2147/opth.s7631) | Abstract References ORCID | 160.73 | 138 |
| 33 | Impact of antibiotic resistance in the management of ocular… (10.2147/opth.s5778) | Abstract References ORCID | 160.02 | 135 |
| 34 | Age-related macular degeneration: current treatments (10.2147/opth.s2094) | Abstract References ORCID License | 157.98 | 37 |
| 35 | Unilateral retinitis pigmentosa and cone-rod dystrophy (10.2147/opth.s5130) | Abstract References ORCID License | 157.98 | 37 |
| 36 | Ectasia risk factors in refractive surgery (10.2147/opth.s51313) | Abstract References ORCID | 157.01 | 123 |
| 37 | Impact of injection therapy on retinal patients with diabeti… (10.2147/opth.s100168) | Abstract References ORCID | 156.74 | 122 |
| 38 | Epiretinal membrane: optical coherence tomography-based diag… (10.2147/opth.s97722) | Abstract References ORCID | 156.48 | 121 |
| 39 | The Sensimed Triggerfish contact lens sensor: efficacy, safe… (10.2147/opth.s109708) | Abstract References ORCID | 156.21 | 120 |
| 40 | Ahmed glaucoma valve implant: surgical technique and complic… (10.2147/opth.s104220) | Abstract References ORCID | 155.67 | 118 |
| 41 | Dexamethasone intravitreal implant in the treatment of diabe… (10.2147/opth.s79948) | Abstract References ORCID | 155.11 | 116 |
| 42 | The Prospective Health Assessment of Cataract Patients&r… (10.2147/opth.s120159) | Abstract References ORCID | 154.83 | 115 |
| 43 | Anti-VEGF treatment of diabetic macular edema in clinical pr… (10.2147/opth.s128509) | Abstract References ORCID | 154.83 | 115 |
| 44 | Tear film osmolarity and dry eye disease: a review of the li… (10.2147/opth.s95242) | Abstract References ORCID | 154.83 | 115 |
| 45 | Causes and correction of dissatisfaction after implantation… (10.2147/opth.s114890) | Abstract References ORCID | 154.55 | 114 |
| 46 | Topical nepafenac in the treatment of diabetic macular edema (10.2147/opth.s3965) | Abstract References ORCID License | 154.41 | 34 |
| 47 | Intense pulsed light for evaporative dry eye disease (10.2147/opth.s139894) | Abstract References ORCID | 153.69 | 111 |
| 48 | Cataract formation following vitreoretinal procedures (10.2147/opth.s68661) | Abstract References ORCID | 153.10 | 109 |
| 49 | Homonymous hemianopia: challenges and solutions (10.2147/opth.s59452) | Abstract References ORCID | 152.51 | 107 |
| 50 | Teleophthalmology: improving patient outcomes? (10.2147/opth.s80487) | Abstract References ORCID | 151.90 | 105 |